It is well known that neuroinflammation in glial cells can increase the release of presynaptic glutamate, thereby activating postsynaptic mGluR5 in trigeminal neuralgia (Honda et al., 2017). The gene discussed is GRM5; the disease is trigeminal nerve disorder.